Publications de 2008

1.     AYOUBA A, BADAUT C, KFUTWAH A, CANNOU C, JUILLERAT A, GANGNARD S, BEHR C, MERCEREAU-PUIJALON O, BENTLEY GA, BARRÉ-SINOUSSI F AND MENU E. Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum. AIDS 2008, 22:785–789 

2.     CAMARA M., D’ALMEIDA C, ORSI F. and CORIAT. B. (2008) “Procurement Policies, Governance Models and ARV Availability in French-Speaking African Countries. An Overview”, in Coriat (ed) (2008) The Political Economy of HIV/AIDS in developing Countries. TRIPS, Public Health Systems and Free Access, Edward Elgar Publisher, London

3.     D'Almeida C, Hasenclever L, Krikorian G, et al. New Antiretroviral Treatments and Post-2005 TRIPS Constraints. First Moves towards IP Flexibilisation in Developing Countries. The Political Economy Of Hiv/Aids In Developing Countries. TRIPS, Public Health Systems and Free Access Edward Elgar, 2008

4.     EBOKO Fred, 2008 « Botswana, Cameroun : deux approches dans l’accès aux antirétroviraux », Transcriptases (France), numéro spécial Compte-rendu de la XVII° conférence internationale sur le sida, Mexico, 3-8 août 2008, ANRS, n° 138, pp. 51-54.                                                                       

5.     KOUANFACK C, LAURENT C, PEYTAVIN G, CIAFFI L, NGOLLE M, NKENE YM, ESSOMBA C, CALMY A, MPOUDI-NGOLÉ E, DELAPORTE E, KOULLA-SHIRO S. Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon. J Acquir Immune Defic Syndr 2008,48(2):216-9.  

6.     LAURENT C, BOURGEOIS A, MPOUDI-NGOLÉ E, CIAFFI L, KOUANFACK C, MOUGNUTOU R, NKOUÉ N, CALMY A, KOULLA-SHIRO S, DELAPORTE E. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. AIDS Res Hum Retroviruses 2008,24(3): 393-9.

7.     LOCATELLI S, LAFAY B, LIEGEOIS F, TING N, DELAPORTE E, PEETERS M. Full molecular characterization of a simian immunodeficiency virus, SIVwrcpbt from Temminck's red colobus (Piliocolobus badius temminckii) from Abuko Nature Reserve, The Gambia.  Virology. 2008 Jun 20;376(1):90-100. Epub 2008 Apr 28.

8.     LOCATELLI S, LIEGEOIS F, LAFAY B, ROEDER AD, BRUFORD MW, FORMENTY P, NOË R, DELAPORTE E, PEETERS M. Prevalence and genetic diversity of simian immunodeficiency virus infection in wild-living red colobus monkeys (Piliocolobus badius badius) from the Taï forest, Côte d'Ivoire SIVwrc in wild-living western red colobus monkeys.  Infect Genet Evol. 2008 Jan;8(1):1-14. Epub 2007 Sep 4. 

9.     MAKINSON A, LE MOING V, KOUANFACK C, LAURENT C, DELAPORTE E.  Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.  Expert Opin Drug Saf 2008, 7(3): 283-93.

10.   MARCELLIN F., BOYER S., PROTOPOPESCU C., DIA A., ONGOLO-ZOGO P., KOULLA-SHIRO S., ABEGA S.C., ABÉ C., MOATTI J.P., SPIRE B., CARRIERI M.P. “Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116)”.  Trop Med Int Health 2008; 13(12):1470-8.

11.   ROUET ET AL., 2008. In-house HIV-1 RNA real-time reverse transcription PCR assays: principle, available tests and usefulness in developing countries.  Exp Rev Mol Diagn, 8(5) : 635-50.

12.   TANTCHOU J. (2008), Les nouveaux acteurs de la lutte contre le sida : chevauchement et revendication d’utilité au sein des structures existantes,  Médecine Tropicale, 68 : 299-304.